Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Dela Peña I, Sanberg PR, Acosta S, Tajiri N, Lin SZ, Borlongan CV.

J Neurosurg Sci. 2014 Sep;58(3):145-9. Epub 2014 May 20. Review.

2.

Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.

Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, Song S, Kaneko Y, Borlongan CV.

PLoS One. 2014 Mar 12;9(3):e90953. doi: 10.1371/journal.pone.0090953. eCollection 2014.

3.

G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury.

De La Peña I, Sanberg PR, Acosta S, Lin SZ, Borlongan CV.

Cell Transplant. 2015;24(3):447-57. doi: 10.3727/096368915X686913. Epub 2015 Feb 2. Review.

PMID:
25646620
4.

Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.

Peña Id, Borlongan CV.

Transl Stroke Res. 2015 Dec;6(6):421-9.

5.

Enhancement in cognitive function recovery by granulocyte-colony stimulating factor in a rodent model of traumatic brain injury.

Sikoglu EM, Heffernan ME, Tam K, Sicard KM, Bratane BT, Quan M, Fisher M, King JA.

Behav Brain Res. 2014 Feb 1;259:354-6. doi: 10.1016/j.bbr.2013.11.008. Epub 2013 Nov 14.

PMID:
24239694
6.

Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans.

Banks WA, Dohi K, Hansen K, Thompson HJ.

Brain Behav Immun. 2016 Feb;52:81-7. doi: 10.1016/j.bbi.2015.10.002. Epub 2015 Oct 9.

PMID:
26441136
7.

Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury.

Yang DY, Chen YJ, Wang MF, Pan HC, Chen SY, Cheng FC.

Neurol Res. 2010 Dec;32(10):1041-9. doi: 10.1179/016164110X12807570510013. Epub 2010 Aug 31.

PMID:
20810026
8.

Comparison of transplantation of bone marrow stromal cells (BMSC) and stem cell mobilization by granulocyte colony stimulating factor after traumatic brain injury in rat.

Bakhtiary M, Marzban M, Mehdizadeh M, Joghataei MT, Khoei S, Pirhajati Mahabadi V, Laribi B, Tondar M, Moshkforoush A.

Iran Biomed J. 2010 Oct;14(4):142-9.

9.

Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury.

Shultz SR, Tan XL, Wright DK, Liu SJ, Semple BD, Johnston L, Jones NC, Cook AD, Hamilton JA, O'Brien TJ.

J Neurotrauma. 2014 May 15;31(10):976-83. doi: 10.1089/neu.2013.3106. Epub 2014 Mar 7.

10.

Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.

Arien-Zakay H, Gincberg G, Nagler A, Cohen G, Liraz-Zaltsman S, Trembovler V, Alexandrovich AG, Matok I, Galski H, Elchalal U, Lelkes PI, Lazarovici P, Shohami E.

J Neurotrauma. 2014 Aug 15;31(16):1405-16. doi: 10.1089/neu.2013.3270. Epub 2014 Jul 14.

11.
12.

Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.

Kumar A, Loane DJ.

Brain Behav Immun. 2012 Nov;26(8):1191-201. doi: 10.1016/j.bbi.2012.06.008. Epub 2012 Jun 21. Review.

PMID:
22728326
13.

Stem cell therapy for sequestering neuroinflammation in traumatic brain injury: an update on exosome-targeting to the spleen.

Crowley MG, Liska MG, Borlongan CV.

J Neurosurg Sci. 2017 Jun;61(3):291-302. doi: 10.23736/S0390-5616.16.03921-7. Epub 2016 Nov 30. Review.

PMID:
27901327
14.

Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury.

Song S, Kong X, Acosta S, Sava V, Borlongan C, Sanchez-Ramos J.

J Neurosci Res. 2016 May;94(5):409-23. doi: 10.1002/jnr.23714. Epub 2016 Jan 29.

15.

Umbilical cord blood cell and granulocyte-colony stimulating factor: combination therapy for traumatic brain injury.

de la Peña I, Sanberg PR, Acosta S, Lin SZ, Borlongan CV.

Regen Med. 2014;9(4):409-12. doi: 10.2217/rme.14.32. No abstract available.

PMID:
25159056
16.

The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.

Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME.

Recent Pat CNS Drug Discov. 2013 Apr;8(1):2-12. Review.

17.

Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice.

Fenn AM, Skendelas JP, Moussa DN, Muccigrosso MM, Popovich PG, Lifshitz J, Eiferman DS, Godbout JP.

J Neurotrauma. 2015 Jan 15;32(2):127-38. doi: 10.1089/neu.2014.3514. Epub 2014 Nov 13.

18.
19.

Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Marklund N, Hillered L.

Br J Pharmacol. 2011 Oct;164(4):1207-29. doi: 10.1111/j.1476-5381.2010.01163.x. Review.

20.

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities.

Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, Borlongan CV.

Neuropsychiatr Dis Treat. 2015 Jan 8;11:97-106. doi: 10.2147/NDT.S65815. eCollection 2015. Review.

Supplemental Content

Support Center